Drug Price Trends for NDC 62011-0474

Average Pharmacy Cost for 62011-0474

Drug Name	NDC	Price/Unit ($)	Unit	Date
HM STOOL SOFTENER 250 MG SFTGL	62011-0474-01	0.05339	EACH	2025-07-23
HM STOOL SOFTENER 250 MG SFTGL	62011-0474-01	0.05295	EACH	2025-06-18
HM STOOL SOFTENER 250 MG SFTGL	62011-0474-01	0.05152	EACH	2025-05-21

Best Wholesale Price for NDC 62011-0474

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

Market Analysis and Price Projections for NDC 62011-0474

Last updated: April 2, 2026

What is NDC 62011-0474?

NDC 62011-0474 is a medication approved by the U.S. Food and Drug Administration (FDA). It is identified as [drug name] (brand name, if applicable). It is indicated for [specific condition or indication]. The drug is delivered in [form, e.g., injectable, tablet, etc.], with a typical dosage regimen of [dosage details].

Market Landscape

Current Market Size

• Estimated global market is valued at approximately $X billion in 2023.
• The U.S. holds XX% of the market, equating to roughly $X billion.
• The market has grown at a compound annual growth rate (CAGR) of approximately X% over the past five years.

Competitive Environment

• The drug competes against [list of main competitors], including:

  • [Drug A] (brand name, if applicable)
  • [Drug B]
  • [Drug C]

• Key differentiators include:

  • Efficacy profile
  • Side effect profile
  • Route of administration
  • Pricing strategy

Regulatory and Reimbursement Factors

• Approved through [review pathway, e.g., NDA, BLA] in [year].
• Covered by major insurers with reimbursement rates averaging X% of billed charges.
• The drug's approval status and reimbursement landscape influence market penetration.

Key Market Drivers and Barriers

• Drivers:

  • Increasing prevalence of [condition].
  • Advances in formulation improving patient compliance.
  • Expanding indications approved by FDA.

• Barriers:

  • High manufacturing costs.
  • Competition from biosimilars or generics.
  • Pricing pressures from payers and health authorities.

Price Projections

Current Pricing Benchmarks

• List price: $X per unit/dose.
• Average wholesale price (AWP): $X.
• Customer net price (after discounts): estimated at $X.

Short-term Forecast (Next 1-2 Years)

• Expected price range: $X - $Y.
• Factors influencing prices:
  • Market entry of biosimilars, if applicable.
  • Negotiated payer discounts.
  • Potential for price increases due to inflation or supply chain costs.

Long-term Outlook (3-5 Years)

• Price stability or growth projected at X% annually.
• Likely impact of patent expiry and biosimilar competition on pricing.
• Potential for formulary inclusion and managed care negotiations to suppress prices further.

Comparative Price Analysis

Parameter	NDC 62011-0474	Main Competitors
List Price	$X per dose	$Y per dose
Average Wholesale Price	$X	$Y
Estimated Net Price	$Z	$W

Market Entry and Growth Strategies

• Expanding indications can drive higher sales volumes.
• Formulary placement and strategic negotiations will influence pricing.
• Differentiation through improved delivery systems or manufacturing efficiency can sustain margins.

Risks to Price and Market Share

• Regulatory delays or additional approvals.
• Emergence of generics or biosimilars.
• Payer pressure to reduce reimbursement levels.
• Changes in clinical guidelines that favor alternative therapies.

Summary

NDC 62011-0474 is situated within a competitive landscape with a current list price around $X. The drug's market is driven by rising prevalence of its target condition, with potential for price stabilization or modest growth over the next three years. Long-term pricing will largely depend on patent exclusivity, regulatory developments, and competitive dynamics.

Key Takeaways

• The market for NDC 62011-0474 exceeds $X billion globally, with steady growth.
• Its pricing is influenced by competition from biosimilars, formulary negotiations, and manufacturing costs.
• Short-term price stability is expected; long-term prices will face downward pressure from biosimilar entry.
• Expanding indications can improve market share and justify higher prices.
• Reimbursement landscape plays a significant role in overall revenue potential.

FAQs

1. What factors influence the pricing of NDC 62011-0474?
   Manufacturing costs, competition, reimbursement policies, and market demand.

2. How does the competition affect future prices?
   Biosimilar entries and generics typically lead to reduced prices and margins.

3. What is the potential for market growth?
   Growing prevalence of target condition, new indications, and better patient access can expand the market.

4. When is patent expiry expected, and what impact will it have?
   Patent expiration is projected for [year], likely causing a decrease in price due to biosimilar competition.

5. How do reimbursement dynamics influence profitability?
   Higher reimbursement rates support pricing power; payer discounts and formulary restrictions can limit revenue.

References

1. [1] FDA. (2023). Drug approval information.
2. [2] IQVIA. (2023). Pharmaceutical market analysis report.
3. [3] Generic and biosimilar market outlook. (2023). Industry analysis report.